IP Library › Granted Patent US 7,300,931
Granted Patent B2
US 7,300,931 · App. 11/321,419 · Granted Nov 27, 2007

Compositions for treating cell proliferation disorders

Assignee: Kinex Pharmaceuticals, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,300,931
App. No.
11/321,419
Granted
Nov 27, 2007
Kind
B2
Abstract

The invention relates to compounds and methods for treating cell proliferation disorders.

Claims (14)

1. A compound according to the formula

or a salt, tautomer, solvate, hydrate, or prodrug thereof.

2. The compound of claim 1 , wherein said compound is a solvate.

3. The compound of claim 1 , wherein said compound is a hydrate.

4. The compound of claim 1 , wherein said compound is an acid addition salt.

5. A composition comprising a compound according to claim 1 and at least one pharmaceutically acceptable excipient.

6. A compound having the formula:

7. A composition comprising the compound

and at least one pharmaceutically acceptable excipient.

8. A pharmaceutically acceptable salt of a compound having the formula:

9. The salt of claim 8 , wherein the salt is a hydrochloride salt.

10. A composition comprising a pharmaceutically acceptable salt of a compound having the formula:

and at least one pharmaceutically acceptable excipient.

11. The composition of claim 10 , wherein the salt is a hydrochloride salt.

Assignments (9)
SECURITY INTEREST Recorded Sep 16, 2022
From: ATHENEX, INC.
To: SAGARD HEALTHCARE ROYALTY PARTNERS, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 061119/0681 →
SECURITY INTEREST Recorded Sep 16, 2022
From: ATNX SPV, LLC
To: SAGARD HEALTHCARE ROYALTY PARTNERS, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 061119/0920 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2022
From: ATHENEX, INC.
To: ATNX SPV, LLC
Reel/Frame 061071/0086 →
SECURITY INTEREST Recorded Jun 22, 2020
From: ATHENEX, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 053005/0657 →
RELEASE OF SECURITY INTEREST Recorded Jun 19, 2020
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: ATHENEX, INC.
Reel/Frame 052990/0677 →
PATENT SECURITY AGREEMENT Recorded Jul 3, 2018
From: ATHENEX, INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 047247/0812 →
CHANGE OF NAME Recorded Sep 21, 2015
From: KINEX PHARMACEUTICALS, INC.
To: ATHENEX, INC.
Reel/Frame 036644/0296 →
CHANGE OF NAME Recorded Sep 10, 2015
From: KINEX PHARMACEUTICALS, LLC
To: KINEX PHARMACEUTICALS, INC.
Reel/Frame 036585/0786 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 7, 2006
From: HANGAUER, JR., DAVID G.
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 017614/0304 →
Continuity (4)
Provisional Application 6072734100 · Oct 17, 2005
Provisional Application 6070455100 · Aug 1, 2005
Provisional Application 6063983400 · Dec 28, 2004
Related Publication 20060160800A1 · Jul 20, 2006